Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine in Initial Cardioplegia
2014-001382-26Phase 4Completed
- Sponsor
- Tampere Heart Hospital
- Start
- Apr 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of adenosine in coronary arteriosclerosis and aortic stenosis (AS), sponsored by Tampere Heart Hospital. Primary endpoint: global myocardial strain. Started Apr 2014; status: completed.
02
Drugs
adenosine
03
Conditions
coronary arteriosclerosisaortic stenosis (AS)
Beyond the preview
Go deeper on 2014-001382-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001382-26.